02
DEC
2011

Northwest Bio Implements Major Balance Sheet Clean-Up

Posted By :
Comments : Off
Removes $31.5 Million Of Liabilities Bethesda, Maryland, December 2, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) (Northwest Bio) announced today that it has implemented a major clean-up of its balance sheet, removing $31.5 million of liabilities through settlement, retirement and conversion. This restructuring reduces the Company’s liabilities from $48 million at the end of the third quarter to $16.5 million. Only about $2.3...
Read More
17
NOV
2011

Northwest Bio Announces Transactions For $5.4 Million In New Financing

Posted By :
Comments : Off
$2.4 Million Immediate Funding and Agreement to Purchase First $3 Million of New Shares Under Pending Equity Facility BETHESDA, MD, November 17, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) (Northwest Bio) today announced $2.4 million in new funding under favorable loan terms, as well as an agreement to purchase the first $3 million in shares of common stock under the previously announced agreement for an equity facility of up to...
Read More
15
NOV
2011

Northwest Bio To Present At Society Of Neuro-Oncology Annual Meeting

Posted By :
Comments : Off
Premier Gathering of Neuro-Oncology Specialists from Across the US and Abroad Multiple Company Initiatives During Four-Day Meeting BETHESDA, MD, November 15, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) (Northwest Bio) today announced that it will participate in the annual meeting of the Society of NeuroOncology (SNO) to be held at the Hyatt Regency, Orange County, California from November 17-20. SNO is the premier professional...
Read More
01
NOV
2011

Northwest Bio Announces Interview Of CEO Linda Powers In Today’s CEO/CFO Publication

Posted By :
Comments : Off
Describes DCVax® Science and Company’s Progress BETHESDA, MD, November 1, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) (Northwest Bio) today announced, as part of its program of public outreach and education, the availability online of an interview of Northwest Bio Chairman and CEO Linda Powers by CEO/CFO Publication. The interview describes in layman’s terms both the encouraging science behind DCVax® and the progress...
Read More
25
OCT
2011

Northwest Bio Announces Initiation Of S&P Coverage, With Publication Of First Company Stock Report

Posted By :
Comments : Off
To Be Made Available To 100,000 Participating Investment Advisors BETHESDA, MD, October 25, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) (NORTHWEST BIO) today announced initiation of Factual Stock Report coverage in conjunct- ion with Standard & Poor’s Market Access Program, an information distribution service that enables subscribing publicly traded companies to have corporate information disseminated to users of...
Read More